EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Oral Trehalose Intake Modulates the Microbiota–Gut–Brain Axis and Is Neuroprotective in a Synucleinopathy Mouse Model

Solène Pradeloux iD, Katherine Coulombe, Alexandre Jules Kennang Ouamba iD, Amandine Isenbrandt, Frédéric Calon iD, Denis Roy iD, Denis Soulet iD

Nutrients · 2024

DOI: 10.3390/nu16193309 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Solène Pradeloux und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre de Recherche du CHU de Québec, Québec, QC G1V 4G2, Canada. Hauptthemen laut MEDLINE: Trehalose, Gastrointestinal Microbiome, Neuroprotective Agents, Disease Models, Animal. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Sentinelle Nord Funds (Excellence Canada), Faculty funds from Université Laval (Trifaculty initiative).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s disease (PD) is a neurodegenerative disease affecting dopaminergic neurons in the nigrostriatal and gastrointestinal tracts, causing both motor and non-motor symptoms. This study examined the neuroprotective effects of trehalose. This sugar is confined in the gut due to the absence of transporters, so we hypothesized that trehalose might exert neuroprotective effects on PD through its action on the gut microbiota. We used a transgenic mouse model of PD (PrP-A53T G2-3) overexpressing human α-synuclein and developing GI dysfunctions. Mice were given water with trehalose, maltose, or sucrose (2% w/v) for 6.5 m. Trehalose administration prevented a reduction in tyrosine hydroxylase immunoreactivity in the substantia nigra (−25%), striatum (−38%), and gut (−18%) in PrP-A53T mice. It also modulated the gut microbiota, reducing the loss of diversity seen in PrP-A53T mice and promoting bacteria negatively correlated with PD in patients. Additionally, trehalose treatment increased the intestinal secretion of glucagon-like peptide 1 (GLP-1) by 29%. Maltose and sucrose, which break down into glucose, did not show neuroprotective effects, suggesting glucose is not involved in trehalose-mediated neuroprotection. Since trehalose is unlikely to cross the intestinal barrier at the given dose, the results suggest its effects are mediated indirectly through the gut microbiota and GLP-1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TrehaloseGastrointestinal MicrobiomeNeuroprotective AgentsDisease Models, AnimalMice, TransgenicBrain-Gut AxisAnimalsMiceHumansSynucleinopathiesMalealpha-SynucleinGlucagon-Like Peptide 1Administration, OralParkinson DiseaseMaltose

Stichwörter der Autor:innen

GLP-1Parkinson’s diseasePrP-A53Tgut microbiotamicrobiota–gut–brain axistrehalose

Substanzen

TrehaloseNeuroprotective Agentsalpha-SynucleinGlucagon-Like Peptide 1Maltose

Autor:innen und Institutionen

  • Centre de Recherche du CHU de Québec, Québec, QC G1V 4G2, Canada.
  • Faculté de Pharmacie, Université Laval, Québec, QC G1V 0A6, Canada.
  • Faculté des Sciences de l'Agriculture et de l'Alimentation, Université Laval, Québec, QC G1V 0A6, Canada.

ORCID-Profile: Solène Pradeloux, Alexandre Jules Kennang Ouamba, Frédéric Calon, Denis Roy, Denis Soulet

Förderung

  • CIHR
  • Sentinelle Nord Funds (Excellence Canada)
  • Faculty funds from Université Laval (Trifaculty initiative)
  • Canadian Funds for Innovation
  • Junior 2 career award from Fonds de Recherche du Québec - Volet Santé
  • Desjardins Training Grant for Research and Innovation from the Fondation du CHU de Québec
  • Fellowship from the Faculty of Pharmacy Teaching and Research Fund (FER), Laval University
  • Université Laval (Trifaculty initiative)

Zitieren

APA

Pradeloux, S., Coulombe, K., Ouamba, A. J. K., Isenbrandt, A., Calon, F., Roy, D., & Soulet, D. (2024). Oral Trehalose Intake Modulates the Microbiota–Gut–Brain Axis and Is Neuroprotective in a Synucleinopathy Mouse Model. Nutrients. https://doi.org/10.3390/nu16193309

Vancouver

Pradeloux S, Coulombe K, Ouamba AJK, Isenbrandt A, Calon F, Roy D, et al. Oral Trehalose Intake Modulates the Microbiota–Gut–Brain Axis and Is Neuroprotective in a Synucleinopathy Mouse Model. Nutrients. 2024. doi:10.3390/nu16193309

BibTeX
@article{Pradeloux2024,
  author = {Pradeloux, Solène and Coulombe, Katherine and Ouamba, Alexandre Jules Kennang and Isenbrandt, Amandine and Calon, Frédéric and Roy, Denis and Soulet, Denis},
  title = {Oral Trehalose Intake Modulates the Microbiota–Gut–Brain Axis and Is Neuroprotective in a Synucleinopathy Mouse Model},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16193309}
}
Kostenlos starten →